COVID-19 and Drug Shortages: A Call to Action.
Level V
Where this comes from
- Record sourced from PubMed, PMID 32715960.
- Also identified by DOI 10.18553/jmcp.2020.26.8.945 and PMC identifier 10391236.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients. DISCLOSURES: The authors declare no funding sources nor conflicts of interest.
Medical subject headings
- Coronavirus Infections
- Pharmaceutical Preparations
- Pharmacies
- Pneumonia, Viral